局部麻醉药物在肿瘤转移和复发中作用的研究进展

doi:10.16352/j.issn.1001-6325.2022.03.015

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (3): 512-515.doi: 10.16352/j.issn.1001-6325.2022.03.015

局部麻醉药物在肿瘤转移和复发中作用的研究进展

刘畅, 郭向阳^*

北京大学第三医院麻醉科, 北京 100191

收稿日期:2020-10-12 修回日期:2021-01-12 出版日期:2022-03-05 发布日期:2022-03-04
通讯作者: ^* puthmzk@hsc.pku.edu.cn
基金资助:
北京大学第三医院院临床重点支持项目(BYSY2017001)

Research advances in the roles of local anesthetics in tumor metastasis and recurrence

LIU Chang, GUO Xiang-yang^*

Department of Anesthesiology, Peking University Third Hospital, Beijing 100191, China

Received:2020-10-12 Revised:2021-01-12 Online:2022-03-05 Published:2022-03-04
Contact: ^* puthmzk@hsc.pku.edu.cn

摘要/Abstract

摘要： 围术期肿瘤治疗常需要使用麻醉药物。不同麻醉药物及麻醉方法的选择会影响肿瘤的增殖、转移复发及预后。围术期应用局部麻醉药物(简称局麻药)不仅能减少阿片类药物的用量,尚能通过阻滞肿瘤细胞钠通道、改变表观遗传学、减轻炎性反应和提高免疫功能等机制发挥抑制肿瘤转移和复发的作用。探讨局麻药在肿瘤转移复发中的作用机制,可为围术期肿瘤患者局麻药的合理使用提供新的策略。

关键词: 麻醉, 肿瘤, 局部麻醉药物, 转移和复发

Abstract: Anesthetics are commonly used in the perioperative treatment of tumor. The choice of different anesthetics and anesthesia techniques will affect the proliferation, metastasis, recurrence and prognosis of cancer. Perioperative applications of local anesthetics can not only reduce the amount of opioids, but also inhibit tumor metastasis and recurrence by blocking sodium channels of cancer cells, changing epigenetics, decreasing inflammation and improving immune function. The exploration of the mechanism of local anesthetics in tumor metastasis and recurrence provides the new strategies for the optimal use of local anesthetics in cancer patient's perioperatively chemotherapy.

Key words: anesthesia, tumor, local anesthetics, metastasis and recurrence

中图分类号:

R614

刘畅, 郭向阳. 局部麻醉药物在肿瘤转移和复发中作用的研究进展[J]. 基础医学与临床, 2022, 42(3): 512-515.

LIU Chang, GUO Xiang-yang. Research advances in the roles of local anesthetics in tumor metastasis and recurrence[J]. Basic & Clinical Medicine, 2022, 42(3): 512-515.

参考文献

[1]Longhini F, Bruni A, Garofalo E, et al. Anesthetic strategies in oncological surgery: not only a simple sleep, but also impact on immunosuppression and cancer recurrence[J]. Cancer Manag Res, 2020, 12: 931-940.
[2]Wang X, Xie W, Gan S, et al. Effects of general anesthesia versus local anesthesia in primary hepatocellular carcinoma patients presenting for thermal ablation surgery: a multiple center retrospective cohort study with propensity score matching[J]. Ann Transl Med, 2020, 8: 277.doi:10.21037/atm.2020.03.88.
[3]Koumpan Y, Jaeger M, Mizubuti GB, et al. Spinal anesthesia is associated with lower recurrence rates after resection of nonmuscle invasive bladder cancer[J]. J Urol, 2018, 199: 940-946.
[4]Pei JP, Zhang CD, Liang Y, et al. Effects of epidural combined with general anesthesia versus general anesthesia alone in gastric cancer surgery: a propensity score matching analysis[J]. Ann Transl Med, 2020, 8: 473.doi:10.21037/atm.2020.03.127.
[5]Chen DT, Pan JH, Chen YH, et al. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target[J]. Br J Anaesth, 2019, 122: e157-e167.
[6]Silagy AW, Hannum ML, Mano R, et al. Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia[J]. Br J Anaesth, 2020, 125: e402-e404.
[7]MacFater WS, Xia W, Barazanchi A, et al. Intravenous local anaesthetic compared with intraperitoneal local anaesthetic in abdominal surgery: a systematic review[J]. World J Surg, 2018, 42: 3112-3119.
[8]Zhang H, Yang L, Zhu X, et al. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study[J]. Br J Anaesth, 2020, 125: 141-148.
[9]Djamgoz MBA, Fraser SP, Brackenbury WJ. In vivo evidence for voltage-gated sodium channel expression in carcinomas and potentiation of metastasis[J]. Cancers, 2019, 11: 1675.doi:10.3390/cancers11111675.
[10]Baptista-Hon DT, Robertson FM, Robertson GB, et al. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function[J]. Br J Anaesth, 2014, 113: i39-i48.
[11]Yildirim S, Altun S, Gumushan H, et al. Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo[J]. Cancer Lett, 2012, 323: 58-61.
[12]Elajnaf T, Baptista-Hon DT, Hales TG. Potent inactiva-tion-dependent inhibition of adult and neonatal NaV1.5 channels by lidocaine and levobupivacaine[J]. Anesth Analg, 2018, 127: 650-660.
[13]Masui K, Harachi M, K. Cavenee W, et al. Codepen-dency of metabolism and epigenetics drives cancer progression: a review[J]. Acta Histochemica Et Cytochemica, 2020, 53: 1-10.
[14]许力凡, 张记, 田志强, 等. 肿瘤抗药性的表观遗传学调控机制[J]. 基础医学与临床, 2013, 33: 1638-1640.
[15]Tada M, Imazeki F, Fukai K, et al. Procaine inhibits the proliferation and DNA methylation in human hepatoma cells[J]. Hepatol Int, 2007, 1: 355-364.
[16]Li K, Yang J, Han X. Lidocaine sensitizes the cytotoxi-city of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation[J]. Int J Mol Sci, 2014, 15: 23519-23536.
[17]Lirk P, Hollmann MW, Fleischer M, et al. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro[J]. Br J Anaesth, 2014, 113: i32-i38.
[18]Johnson MZ, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model[J]. Br J Anaesth, 2018, 121: 76-85.
[19]Saito T, Yamamoto Y, Feng GG, et al. Lidocaine prevents oxidative stress-induced endothelial dysfunction of the systemic artery in rats with intermittent periodontal inflammation[J]. Anesth Analg, 2017, 124: 2054-2062.
[20]Ortiz MP, Godoy MC, Schlosser RS, et al. Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial[J]. J Clin Anesth, 2016, 35: 70-77.
[21]Othman AH, Ahmed DG, Abd El-Rahman AM, et al. Effect of preperitoneal versus epidural analgesia on postoperative inflammatory response and pain following radical cystectomy: a prospective, randomized trial[J]. Clin J Pain, 2019, 35: 328-334.
[22]Hayden JM, Oras J, Block L, et al. Intraperitoneal ropivacaine reduces time interval to initiation of chemotherapy after surgery for advanced ovarian cancer: randomised controlled double-blind pilot study[J]. Br J Anaesth, 2020, 124: 562-570.
[23]Cruz FF, Rocco PR, Pelosi P. Anti-inflammatory proper-ties of anesthetic agents[J]. Crit Care, 2017, 21: 67.doi:10.1186/s13054-017-1645-x.
[24]Cata JP, Ramirez MF, Velasquez JF, et al. Lidocaine stimulates the function of natural killer cells in different experimental settings[J]. Anticancer Res, 2017, 37: 4727-4732.
[25]Wang HL, Yan HD, Liu YY, et al. Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy[J]. Mol Med Rep, 2015, 12: 7039-7044.
[26]Wang L, Liang S, Chen H, et al. The effects of epidural anaesthesia and analgesia on T lymphocytes differentiation markers and cytokines in patients after gastric cancer resection[J]. BMC Anesthesiol, 2019, 19: 102.doi:10.1186/s12871-019-0778-7.

局部麻醉药物在肿瘤转移和复发中作用的研究进展

Research advances in the roles of local anesthetics in tumor metastasis and recurrence

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	夏雨佳, 杨振丽, 刘玉琴. 肿瘤类器官临床前转化研究及应用[J]. 基础医学与临床, 2024, 44(9): 1214-1218.
[2]	刘保清, 黄容, 卢艳, 李凯, 张宁, 刘长征, 宋伟. 胃癌类器官在基础研究与临床应用中的进展[J]. 基础医学与临床, 2024, 44(9): 1219-1222.
[3]	李阳, 朱蕾. 真核延伸因子2激酶是治疗肿瘤的潜在新靶标[J]. 基础医学与临床, 2024, 44(7): 1039-1043.
[4]	陈笑天, 陈翀, 罗云萍. MAFB对肿瘤相关巨噬细胞极化及功能的影响[J]. 基础医学与临床, 2024, 44(7): 965-973.
[5]	谭树芬, 何利平, 杨琳琳, 杨谢兰, 杨宏英, 姚明姣, 李树清. TBL与工作坊整合教学法在妇科肿瘤学临床教学中的应用[J]. 基础医学与临床, 2024, 44(7): 1054-1057.
[6]	周玥, 童安莉. 嗜铬细胞瘤/副神经节瘤免疫微环境[J]. 基础医学与临床, 2024, 44(6): 742-747.
[7]	张沥元, 杜函泽, 潘慧. 治疗下丘脑性肥胖的药物研究进展[J]. 基础医学与临床, 2024, 44(5): 729-732.
[8]	王婷婷, 郭丹, 陆君阳, 徐徕, 董海涛, 林佃新, 肖毅. 结直肠神经内分泌肿瘤细胞突变类型分析[J]. 基础医学与临床, 2024, 44(4): 523-527.
[9]	王子豪, 夏小超, 李舜. 跨膜蛋白质在恶性肿瘤中作用的研究进展[J]. 基础医学与临床, 2024, 44(3): 398-402.
[10]	吴玉红, 喻才元, 叶石才. NMES1基因在恶性肿瘤中作用的研究进展[J]. 基础医学与临床, 2024, 44(3): 403-407.
[11]	南璐, 郭梦杰, 高雅楠, 贾红燕. 膜联蛋白A家族成员在乳腺癌中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(3): 393-397.
[12]	陈雪, 罗添, 魏超君. 溶血磷脂酰胆碱酰基转移酶1在肿瘤中作用的研究进展[J]. 基础医学与临床, 2024, 44(2): 256-259.
[13]	刘宛榕, 赵林. 颅内生殖细胞肿瘤的药物治疗[J]. 基础医学与临床, 2024, 44(10): 1350-1356.
[14]	刘林弟, 吕庆杰. GPSM2在肿瘤中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(10): 1447-1450.
[15]	李文超, 李祥生, 李富光, 张志永, 惠磊, 周文科. 长链非编码RNA与疾病[J]. 基础医学与临床, 2024, 44(10): 1465-1469.